Literature DB >> 17920698

High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.

Jinzhu Li1, William Ridgway, C Garrison Fathman, Harley Y Tse, Michael K Shaw.   

Abstract

Analysis of T regulatory cells (Treg) and T effector cells (Teff) in experimental autoimmune encephalomyelitis is complicated by the fact that both cell types express CD4 and CD25. We demonstrate that encephalitogenic T cells, following antigen recognition, up-regulate cell surface expression of CD4. The CD4(high) sub-population contains all of the antigen response as shown by proliferation and cytokine secretion, and only these cells are capable of transferring EAE to naive animals. On the other hand, a FACS separable CD25(+) sub-population of cells displayed consistent levels of CD4 prior to and after antigen stimulation. These cells displayed characteristics of Treg, such as expressing high levels of the Foxp3 gene and the ability to suppress mitogenic T cell responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920698      PMCID: PMC2212588          DOI: 10.1016/j.jneuroim.2007.09.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

1.  Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals.

Authors:  E Allison Green; Yongwon Choi; Richard A Flavell
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

2.  Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.

Authors:  K Lejon; C G Fathman
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

3.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

Authors:  C B Pettinelli; D E McFarlin
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility.

Authors:  C C Bernard
Journal:  J Immunogenet       Date:  1976-08

5.  Precursor frequency of antigen-specific T cells: effects of sensitization in vivo and in vitro.

Authors:  D Ford; D Burger
Journal:  Cell Immunol       Date:  1983-07-15       Impact factor: 4.868

6.  In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture.

Authors:  H M Gebel; J R Scott; C A Parvin; G E Rodey
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

8.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

Authors:  Thomas Korn; Jayagopala Reddy; Wenda Gao; Estelle Bettelli; Amit Awasthi; Troels R Petersen; B Thomas Bäckström; Raymond A Sobel; Kai W Wucherpfennig; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Med       Date:  2007-03-25       Impact factor: 53.440

9.  Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation.

Authors:  Y Kuniyasu; T Takahashi; M Itoh; J Shimizu; G Toda; S Sakaguchi
Journal:  Int Immunol       Date:  2000-08       Impact factor: 4.823

10.  Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis.

Authors:  Jayagopala Reddy; Zsolt Illes; Xingmin Zhang; Jeffrey Encinas; Jason Pyrdol; Lindsay Nicholson; Raymond A Sobel; Kai W Wucherpfennig; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

View more
  3 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

2.  Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Authors:  Leyre Mestre; Francisco Javier Carrillo-Salinas; Miriam Mecha; Ana Feliú; Carmen Espejo; José Carlos Álvarez-Cermeño; Luisa María Villar; Carmen Guaza
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

3.  Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS.

Authors:  Ken Flanagan; Kent Fitzgerald; Jeanne Baker; Karin Regnstrom; Shyra Gardai; Frederique Bard; Simonetta Mocci; Pui Seto; Monica You; Catherine Larochelle; Alexandre Prat; Samuel Chow; Lauri Li; Chris Vandevert; Wagner Zago; Carlos Lorenzana; Christopher Nishioka; Jennifer Hoffman; Raquel Botelho; Christopher Willits; Kevin Tanaka; Jennifer Johnston; Ted Yednock
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.